Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Moderate COVID-19-infection”

Showing 20 of 0 results

Large-scale testing (Phase 3)UnknownNCT04826822
What this trial is testing

Spironolactone and Dexamethasone in Patients Hospitalized With COVID-19

Who this might be right for
Coronavirus InfectionPneumonia, Viral
Chita State Regional Clinical Hospital Number 1 440
Testing effectiveness (Phase 2)Study completedNCT05941793
What this trial is testing

Evaluate the Efficacy, Safety, and Concentration of SNS812 in Mild to Moderate COVID-19 Patients

Who this might be right for
Mild to Moderate COVID-19
Oneness Biotech Co., Ltd. 135
Testing effectiveness (Phase 2)Study completedNCT04427098
What this trial is testing

Enoxaparin in COVID-19 Moderate to Severe Hospitalized Patients

Who this might be right for
COVID-19
IRCCS Azienda Ospedaliero-Universitaria di Bologna 301
Not applicableStudy completedNCT04512027
What this trial is testing

Prolectin-M in COVID-19 Patients Having Mild to Moderate Symptoms Not Requiring Oxygen Support.

Who this might be right for
COVID-19
Composite Interceptive Med Science 10
Testing effectiveness (Phase 2)Ended earlyNCT04363437
What this trial is testing

COlchicine in Moderate-severe Hospitalized Patients Before ARDS to Treat COVID-19

Who this might be right for
Coronavirus Infection
Maimonides Medical Center 21
Testing effectiveness (Phase 2)UnknownNCT05689203
What this trial is testing

Evaluate the Efficacy and Safety of QLS1128 Orally in Symptomatic Participants With Mild to Moderate COVID-19

Who this might be right for
COVID-19
Qilu Pharmaceutical Co., Ltd. 360
Testing effectiveness (Phase 2)Looking for participantsNCT05787327
What this trial is testing

RCT for Yinqiaosan-Maxingganshitang in the Treatment of COVID-19

Who this might be right for
COVID-19
Chinese University of Hong Kong 96
Not applicableUnknownNCT06223932
What this trial is testing

Evaluation of the Efficacy and Safety of Molnupiravir Treatment in Mild/Moderate Covid-19 Patients.

Who this might be right for
COVID-19SARS-CoV-2 Infection
Serap Yavuz 2,600
Testing effectiveness (Phase 2)UnknownNCT04760821
What this trial is testing

Prevention of Acute Myocardial Injury by Trimetazidine in Patients Hospitalized for COVID-19

Who this might be right for
Acute Respiratory Distress SyndromeCovid19Myocardial Injury
Ministry of Health, Brazil 80
Testing effectiveness (Phase 2)Study completedNCT05092503
What this trial is testing

JINZHEN for Treatment of Mild to Moderate COVID-19

Who this might be right for
COVID-19
Lianyungang Kanion Group, Ltd. 60
Testing effectiveness (Phase 2)Study completedNCT05069610
What this trial is testing

Evaluating Safety, Tolerability, and Potential Efficacy of Intranasal AD17002 in Adults With Mild to Moderate COVID-19

Who this might be right for
COVID-19
Advagene Biopharma Co. Ltd. 30
Early research (Phase 1)Study completedNCT04766931
What this trial is testing

The Safety and Efficacy of FB2001 in Healthy Subjects and Patients With COVID-19 Infection

Who this might be right for
Covid19
Frontier Biotechnologies Inc. 88
Early research (Phase 1)Study completedNCT04582201
What this trial is testing

A Clinical Trial to Evaluate the Safety of agenT-797 in COVID-19 Participants With ARDS

Who this might be right for
Respiratory Distress Syndrome, Adult
MiNK Therapeutics 20
Early research (Phase 1)Study completedNCT05005312
What this trial is testing

Study to Estimate the Effects of Hepatic Impairment on the Pharmacokinetics (PK) of PF-07321332

Who this might be right for
Hepatic Impairment
Pfizer 17
Testing effectiveness (Phase 2)Study completedNCT04523181
What this trial is testing

Double-blind Study to Evaluate the Safety and Efficacy of Antroquinonol in Mild-Moderate COVID-19 Hospitalized Patients

Who this might be right for
Covid-19
Golden Biotechnology Corporation 124
Not applicableUnknownNCT04429711
What this trial is testing

Ivermectin vs. Placebo for the Treatment of Patients With Mild to Moderate COVID-19

Who this might be right for
COVID-19
Sheba Medical Center 100
Post-approval studies (Phase 4)UnknownNCT04350671
What this trial is testing

Interferon Beta 1a in Hospitalized COVID-19 Patients

Who this might be right for
COVID-19
Shahid Beheshti University of Medical Sciences 40
Large-scale testing (Phase 3)UnknownNCT05908071
What this trial is testing

Study Evaluating SHEN26 Capsule in Patients With Mild to Moderate COVID-19

Who this might be right for
COVID-19
Shenzhen Kexing Pharmaceutical Co., Ltd. 1,200
Testing effectiveness (Phase 2)Study completedNCT04701658
What this trial is testing

A Real World Study of Bamlanivimab in Participants With Mild-to-Moderate Coronavirus Disease 2019 (COVID-19)

Who this might be right for
COVID-19
Eli Lilly and Company 109
Testing effectiveness (Phase 2)Study completedNCT04533347
What this trial is testing

Tafenoquine in Patients With Mild to Moderate COVID-19

Who this might be right for
COVID 19 Disease
60 Degrees Pharmaceuticals LLC 86
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation